<HTML xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
<style type="text/css">
A:before { content:' '; } 
A:after { content:' '; } 
SPAN:before { content:' '; } 
SPAN:after { content:' '; } 
</style>
<BODY class="mediawiki  ltr ns-0 ns-subject page-Team_KULeuven_Description"><DIV id="globalWrapper"><DIV id="top-section"><DIV id="p-logo"><A href="/Main_Page" title="Main Page">&quot;
	    </A></DIV><DIV id="menubar" class="left-menu noprint"><UL><LI class="selected"><A href="/Team:KULeuven/Description">Page               </A></LI><LI class="new"><A href="/wiki/index.php?title=Talk:Team:KULeuven/Description&amp;action=edit&amp;redlink=1">Discussion               </A></LI><LI><A href="/wiki/index.php?title=Team:KULeuven/Description&amp;action=edit">View source               </A></LI><LI><A href="/wiki/index.php?title=Team:KULeuven/Description&amp;action=history">History               </A></LI><LI style="color:#808080;cursor:default">teams</LI></UL></DIV><DIV class="right-menu noprint" id="menubar"><UL><LI id="pt-login"><A href="/wiki/index.php?title=Special:UserLogin&amp;returnto=Team:KULeuven/Description" title="You are encouraged to log in; however, it is not mandatory [o]" accesskey="o">Log in</A></LI></UL></DIV><DIV id="search-controls" class="noprint"><FORM action="/Special:Search" id="searchform"> </FORM></DIV></DIV><DIV id="content"><H1 class="firstHeading">Team:KULeuven/Description</H1><DIV id="bodyContent"><H3 id="siteSub" class="noprint">From 2011.igem.org</H3><P><TITLE>KULeuven iGEM 2011</TITLE></P><UL id="nav"><LI class="off"><A href="https://2011.igem.org/Team:KULeuven">Home</A></LI></UL><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Description">Project</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Description" style="border-bottom:2px solid #000; color:#000;">Description</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Modeling">Modeling</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Thermodynamics">Thermodynamics</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Applications">Applications</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Biobricks">Biobricks</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Notebook">Notebook</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Results">Results</A></LI><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Team">Team</A></LI><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Workshop">Human Practice</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Workshop">Education</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Ethics">Ethics</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Safety">Safety</A></LI><LI><A href="https://2011.igem.org/Team:KULeuven/Law&amp;Patents">Law&amp;Patents</A></LI><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Sponsors">Sponsors</A></LI><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Acknowledgments">Acknowledgments</A></LI><LI class="off"><A href="https://2011.igem.org/Team:KULeuven/Data">Data</A></LI><DIV id="contentbox" style="text-align:justify;"><H3><I>E.D. FROSTI</I> Project description</H3><TABLE width="590" border="0" cellspacing="0" cellpadding="0"><TBODY><TR><TD colspan="4"><P>After stimulation, <I>E.D.Frosti</I> will acquire its desired biological property, i.e. the expression of  <B> Ice Nucleation Protein (INP) to induce ice formation</B>, or the expression of a membrane-attached <B> Antifreeze Protein (AFP) to  prevent ice formation</B>. Upon application in the environment at low temperatures, a cell death mechanism will kill off the cells, though the desired biological activity of the proteins on the membranes will remain. This mechanism  ensures that the bacteria cannot overgrow the environment. </P><P>Importantly, without any  preceding stimulus, no cell death will be induced at low temperatures, so our  organism can be safely stored in the fridge.</P></TD></TR></TBODY></TABLE><H3>Extended project description</H3>



This summer, we are engineering the bacterium <I>E.D. Frosti</I> that induces ice crystallization, using the ice-nucleating protein (<A href="https://2011.igem.org/Team:KULeuven/Inp">INP</A>), or inhibits ice crystal formation, using the anti-freeze protein (<A href="https://2011.igem.org/Team:KULeuven/Afp">AFP</A>), depending on the given stimulus. These proteins will be extracellularly anchored at <I>E.D. Frosti</I>’s cell membrane. Furthermore, it is essential to create a dual-inhibition system, so that INP and AFP can never be expressed at the same time. To test this system, we coupled the production of a particular color to a specific stimulus given to <I> E.D. Frosti</I>. Finally, as a safety mechanism, we installed a <A href="https://2011.igem.org/Team:KULeuven/Input"> suicide mechanism</A> in <I> E.D. Frosti</I>, whose activity is mediated by an “AND”-gate system: the cell death mechanism is only activated when one of the two stimuli is given, AND a sudden decrease in temperature (a cold-shock) occurs. To construct our <I>E.D. Frosti</I> project, we had to create several mechanisms which will be outlined below.<H2>1. Dual inhibition system</H2>
Since <I> E.D. Frosti</I> contains all the genetic information to execute both functions, it is important to make sure that only one type of protein is expressed in one <I> E.D. Frosti</I> cell. We found that a dual inhibition system is a good way to ensure this, as you can see in the next figure. 
When arabinose is added to the medium (stimulus 1), it will induce transcription from the  <I>pBAD</I> promoter (<A href="http://partsregistry.org/Part:BBa_I13453" target="”blank”">BBa_I13453</A>), resulting in  <I>LuxR</I> (<A href=" http://partsregistry.org/Part:BBa_I0462" target="”blank”">BBa_I0462</A>) and <I>LuxI</I> (<A href=" http://partsregistry.org/Part:BBa_C0261" target="”blank”">BBa_C0261</A>) transcripts that are translated into their respective proteins. LuxI is an enzyme that catalyzes the production of N-Acyl homoserine lactones (<A href="http://en.wikipedia.org/wiki/Homoserine_Lactone" target="”blank”">AHLs</A>) from S-adenosyl methionine (SAM)  and acyl-coenzyme A (acyl-CoA).  These AHLs, when bound to LuxR, are able to regulate transcription through binding with a luxR binding site located in promoter regions. In our system, the LuxR-AHL complex will perform a dual task. While it activates the <I>pLux-CI</I> promoter (<A href=" http://partsregistry.org/Part:BBa_R0065" target="”blank”">BBa_R0065</A>), resulting in the transcriptional activation of <I>OmpA-AFP</I> (<A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K584020" target="”blank”"> BBa_K584020]</A>)and <I>MelA </I> (<A href="http://partsregistry.org/Part:BBa_K193602" target="”blank”">BBa_K193602</A>) (2), it acts as a negative regulator of the <I>pLac-Lux</I> promoter (<A href="http://partsregistry.org/Part:BBa_K091100" target="”blank”">BBa_K091100</A>), the transcriptional regulator of stimulus 2, thereby acting as an additional safety mechanism to ensure that no INP can be produced during stimulus 1. 
If we add lactose or IPTG to the medium (stimulus 2), it will activate transcription from  the <I>pLac-Lux</I> promoter , resulting in  <I>INP</I> (<A href="http://partsregistry.org/wiki/index.php?title=Part:BBa_K584024" target="”blank”">BBa_K584024</A>), <I>CI repressor</I> and <I>CrtEBI</I> (<A href=" http://partsregistry.org/Part:BBa_K274100" target="”blank”">BBa_K274100</A>) transcripts that are translated into their specific proteins. The CI repressor will repress the <I>pLux-CI</I> promoter and, thereby specifically inhibiting the production of AFP, while INP is being expressed.<H2>2.a  Expression of AFP and Melanin formation</H2>
If you read how the dual inhibition works, it already will be rather clear how AFP and melanin are produced: when <I>E.D. Frosti</I> takes up the arabinose, it will interact with <I>pBAD</I> and eventually triggers the transcription of <I>OmpA-AFP</I> and <I>MelA</I>.  <I>MelA</I> will induce melanin formation, which gives a black color to our cells. In this way we know that our <I>pLux-CI</I> promoter is activated and that both <I>OmpA-AFP</I> and <I>MelA</I>  are being transcribed and translated. The <I>MelA</I> is an existing BioBrick that the Cambridge_2009 team added to the registry: <A href="http://partsregistry.org/Part:BBa_K274001" target="”blank”"> BBa_K274001 </A> . For more information about <I>MelA</I> you can click <A href="https://2009.igem.org/Team:Cambridge/Project/ME01" target="”blank”"> here </A>.  AFP normally is expressed intracellularly  to prevent freezing of the cytoplasm, but in our system, it was essential that  AFP was extracellularly anchored at the cell membrane, thereby preventing ice formation outside the cell. Therefore, we merged the <I>AFP</I> gene to <I>OmpA</I> via a flexible linker, thereby ensuring the desired extracellular localization of AFP.  If you like to know more about <A href="https://2011.igem.org/Team:KULeuven/Afp"> AFP</A>  in nature and how it functions, you can click <A href="https://2011.igem.org/Team:KULeuven/Afp"> here</A>. <H2>2.b Expression of INP and Lycopene formation</H2>
INP and lycopene are produced as a response to lactose or IPTG uptake by <I> E.D. Frosti </I> from the medium. Lactose/IPTG will interact with the <I>pLac-Lux</I> promoter, so that transcription of  <I>CI repressor</I>, <I>CrtEBI</I> and <I>INP</I> can occur. As discussed above, the CI repressor protein will act as an inhibitor of the <I>pLux-CI </I> promoter. The <A href="http://partsregistry.org/Part:BBa_I742120" target="”blank”"><I>CrtEBI</I> operon </A> encodes the three last enzymes of the cartenoid pathway, that are needed to produce lycopene. <I> E. coli</I> itself is able to produce farnesyl pyrophosphate, which is converted to geranyl geranyl-PP by CrtE, which is transformed to pytoene by CrtB, which finally is modified to a lycopene molecule by CrtI. Lycopene production results in a bright red color, so that we can clearly see that <I>CrtEBI</I> as well as <I> INP </I> are expressed. Many different INPs exist in different organisms and we used the <I>InaZ</I> form from the <I>Pseudomonas syringae</I>. INP already contains a transmembrane domain and its active site is located extracellularly to induce ice nucleation in the environment. Therefore, we do not have to add an extracellular anchor. In fact, in previous iGEM competitions, the <A href="https://2009.igem.org/Team:Berkeley_Wetlab" target="”blank”">Berkeley_wetlab_2009 team </A>has created a biobrick in which they specifically use only the (extracellular) INP-repeats as a cell-surface displayer spacer part, to improve the display of passenger domains: <A href="http://partsregistry.org/Part:BBa_K197026" target="”blank”"> BBa_K197026 </A>. If you like to learn more about <A href="https://2011.igem.org/Team:KULeuven/Inp"> INP</A>, feel free to click <A href="https://2011.igem.org/Team:KULeuven/Inp"> here</A>! <H2>3. Cell death mechanism</H2>
We want <I>E.D. Frosti</I> to be coated with one of the two proteins, but we also want <I>E.D. Frosti</I> to die when we release it into the environment. Therefore, we created a suicide mechanism that is regulated by an AND-gate system. First, <I>E.D. Frosti</I> needs to respond to one of the stimuli, so that the <I>pLac-Lux</I> or the <I>pLux-CI</I> promoter is activated resulting in transcriptional activation.  The second part of the cell death mechanism works via a ribokey-ribolock system. The ribokey is under the control of the HybB cold-sensitive promoter (<A href="http://partsregistry.org/Part:BBa_J45503" target="”blank”">BBa_J45503</A>), which will only be switched on when <I>E.D. Frosti</I> senses a dramatic drop of the temperature. So when the ribokey isn’t transcribed, the ribolock mRNA will form a hairpin structure, so that the ribosomes cannot access double stranded mRNA, and there will be no translation of the <I>CeaB</I> gene. Hence, to activate the cell death mechanism, <I>E.D. Frosti</I>  needs to undergo a cold-shock treatment. <I>E.D. Frosti</I> will ‘sense’ the change in temperature and the ribokey will be transcribed. This ribokey will bind to the ribolock, followed by the opening of the double-stranded mRNA hairpin loop. Under these conditions, ribosomes can bind and translate the <I>CeaB</I> gene. CeaB is a DNase, which can be found in the Colicin E2 operon (<A href="http://partsregistry.org/Part:BBa_K131009" target="blank">BBa_K131009 </A>). CeaB cuts all DNA in <I>E.D. Frosti</I> in small pieces, which results in cell death. We chose to only insert the <I>CeaB</I> gene instead of the whole Colicin E2 operon, since this also contains the <I>CelB</I> gene and the <I>CeiB</I> gene. CelB will induce cell lysis and under these conditions, <I> E.D. Frosti</I> would undergo complete degradation and this is something we want to avoid. We want <I>E.D. Frosti</I> to die, but it needs to retain its form, so that the proteins that are expressed on its cell membrane can retain their activity, even when the DNAse is active. The <I>CeiB</I> gene is an immunity gene, that results in DNase inhibition for the organism that is transcribing the <I>CeiB</I> gene. 
So in summary, our cell death mechanism functions via an AND-gate system, in which both a stimulus and a cold-shock are needed to relieve the transcriptional and translational block, resulting in the death of <I> E.D. Frosti</I>.  If you want to know more about bacteriocins or colicins such as <A href="https://2011.igem.org/Team:KULeuven/Input"> CeaB</A>, please click on <A href="https://2011.igem.org/Team:KULeuven/Input"> this link</A>.

</DIV><DIV class="printfooter">
Retrieved from &quot;<A href="http://2011.igem.org/Team:KULeuven/Description">http://2011.igem.org/Team:KULeuven/Description</A>&quot;</DIV></DIV></DIV><DIV id="footer-box" class="noprint"><DIV id="footer"><UL id="f-list"><LI id="t-recentchanges"><A href="/Special:RecentChanges" title="Recent changes">Recent changes</A></LI><LI id="t-whatlinkshere"><A href="/Special:WhatLinksHere/Team:KULeuven/Description" title="List of all wiki pages that link here [j]" accesskey="j">What links here</A></LI><LI id="t-recentchangeslinked"><A href="/Special:RecentChangesLinked/Team:KULeuven/Description" title="Recent changes in pages linked from this page [k]" accesskey="k">Related changes</A></LI><LI id="t-specialpages"><A href="/Special:SpecialPages" title="List of all special pages [q]" accesskey="q">Special pages</A></LI><LI><A href="/Special:Preferences">My preferences</A></LI></UL></DIV><DIV id="footer"><UL id="f-list"><LI id="t-print"><A href="/wiki/index.php?title=Team:KULeuven/Description&amp;printable=yes" title="Printable version of this page [p]" accesskey="p">Printable version</A></LI><LI id="t-permalink"><A href="/wiki/index.php?title=Team:KULeuven/Description&amp;oldid=251289" title="Permanent link to this revision of the page">Permanent link</A></LI><LI id="privacy"><A href="/2011.igem.org:Privacy_policy" title="2011.igem.org:Privacy policy">Privacy policy</A></LI><LI id="disclaimer"><A href="/2011.igem.org:General_disclaimer" title="2011.igem.org:General disclaimer">Disclaimers</A></LI></UL></DIV></DIV></DIV></BODY></HTML>